News - imetelstat, Biotechnology

Filter

Current filters:

imetelstatBiotechnology

Popular Filters

US FDA eases clinical hold on Geron’s imetelstat

US FDA eases clinical hold on Geron’s imetelstat

21-03-2014

There was a touch of good news yesterday for Geron Corp, after the US Food and Drug Administrated partially…

BiotechnologyGeron CorpimetelstatNorth AmericaOncologyRegulationResearchUSA

Geron nosedives on FDA clinical hold for blood disorders drug imetelstat

Geron nosedives on FDA clinical hold for blood disorders drug imetelstat

12-03-2014

USA-based Geron Corp saw its shares plunge 59% to $1.79 when the company revealed that it had received…

BiotechnologyGeron CorpimetelstatNorth AmericaOncologyRegulationResearchUSA

Geron discontinues GRN1005 to concentrate on imetelstat; will cut jobs

05-12-2012

California, USA-based Geron Corp (Nasdaq: GERN), which scrapped its stem cell business a year ago to…

BiotechnologyFinancialGeron CorpGRN1005imetelstatOncologyResearch

Back to top